LPBI India

Official launch of LPBI India

Zoom meeting

On July 19, 2021 at 11AM EST

Members by Geographic Locations

Member Name	Geographical region in India Or Place of Birth in India if now outside of India	Distance from New Delhi	LANGUAGES
Dr (Lt Col) Vivek Lal	Ambuja Nagar, Kodinar (Sasan-Gir) Gujarat.	1300 kms	English, Hindi
Yash Choudhary	Dewas (Madhya Pradesh)	800 kms	English, Hindi
Dr. Premalata Pati	Bhubaneswar, Odisha	1764 kms	English, Hindi, Odia
Dr. Sudipta Saha	Kolkata, West Bengal	1500 kms	English, Hindi, Bengali
Dr. Ajay Gupta	Place of birth: New Delhi	0	English, Hindi
Amandeep Kaur	Kolkata, West Bengal	1500 kms	English, Hindi, Punjabi, Bengali
Pallavi Kaulwar
Aditya Bahl	Lucknow, UP	500	English, Hindi, Punjabi
Srinivas Sriram	Place of Birth: Chennai, Tamil Nadu	2,187 kms	English, Tamil
Abhisar Anand	Place of Birth: Muzaffarpur, Bihar	1,042 kms	English, Hindi
Vaishnavee Joshi
Komal Ingle

ANNOUNCEMENT

Leaders in Pharmaceutical Business Intelligence (LPBI) Group, Boston, MA

is Launching LPBI India on 7/19/2021

LPBI India Official LAUNCH

is on Monday July 19, 2021 at 11AM EST

Aviva – Founder 1.0 LPBI and 2.0 LPBI

Justifying the Launch of LPBI India today is the Interaction between LPBI USA and LPBI India which is taking place multiple times every day
Senior level executive talent in India expressed interest to JOIN LPBI USA while living in India
It was Dr. Lal and Dr. Ghosh interest in joining LPBI USA that impacted Aviva’s Decision toward the Launch of LPBI India: Leadership + Professional Staff
Interactions among all members across India is mostly encouraged
We are preparing a MAP with all the locations in India of our VIRTUAL organization
We are a community of inclusion and excellence challenging and aspiring for expression and growth of the best of our abilities without borders and/or pre-determinants of any kind: age, race, religion or gender
Interactions with Alumni of LPBI USA is mostly encouraged – we are very proud of each of you,

Congratulatory Remarks, each presenter from their own perspective:

LPBI USA Board member, Prof. Marc W. Feldman, Stanford University [7/18/2021 – Medical Emergency] <<< – WE WISH YOU SPEEDY RECOVERY, next Global Zoom on August 10, 2021 – Congratulatory remarks will be delivered
LPBI USA Board member, Prof. Stephen J. Williams, Temple University
Dr. Ajay Gupta of UC, Irvine, [Aviva read loud message sent] LPBI USA, External Scientific Relations
Mr. Aditya Bahl, MBA, [absent] LPBI USA, External Business Relations to LPBI USA since 1/2020. Mr. Bahl is ex-Novastis and ex-J&J, the Founding Director at RAS Life Science Solutions, based in Frankfurt, Germany
Dr. Raphael Nir, Founder, ABI Lab and President, SBH, Inc in Natick, MA – We will have in 4Q’2021 a JOINT meeting dedicated to Mission #2, below

Mission #1:

Medical Text Analysis with Natural Language Processing (NLP), Machine Learning (ML), Artificial Intelligence (AI)

The Medical Text includes FOUR corpuses of content created by the Team at LPBI USA since 4/2012:

1. Scientific Curation Articles published in our Open Access Journal http://pharmaceuticalintelligence.com

N = +6,070, Views = +2Million, with an ontology of +730 categories of Research in the Life Sciences, Medicine, Pharmaceutics and Healthcare

2. 18 e-Books in Medicine https://lnkd.in/ekWGNqA

128,000 page download on Amazon.com – Cover Pages and electronic Table of Contents (eTOCs) of the 18 books are been translated to Spanish in Madrid, now

3. 100 e-Proceedings of Global Medical and Biotech Conferences generated in Real Time, 2013 – 2021 https://pharmaceuticalintelligence.com/press-coverage/part-three-conference-eproceedings-deliverables-social-media-analytics/

4. +6,200 Biological Images with text legend in use by the +6,000 articles – in the Media Gallery of LPBI on WordPress.com cloud. Mission #1 has increased the number of Biological images from 5,100 to +6,200

At LPBI India, been considered for the Leadership function for Mission #1: Dr. Vivek Lal, MD

STRATEGIC PLAN for Mission #1

For scaling up the Text Analysis of these 3.3 Giga Bytes of data we are in alliance with Linguamatics/IQVIA, London https://www.linguamatics.com/what-text-mining-text-analytics-and-natural-language-processing

We jointly presented their NLP results on our content in oncology to a Top HMO/Healthcare Insurer in UT on July 13, 2021. We are invited for additional meetings with both organizations: the HMO and the Healthcare Insurer
LPBI USA developed a ten-phase Protocol for our own content been subjected to Medical Text Analysis with NLP, ML, AI using Wolfram language for BioSciences

LPBI India will be involved in all of the ten-phase Protocol in using NLP, ML, AI

WORKFLOW for a Ten-Steps Medical Text Analysis Operation using NLP on LPBI Medical and Life Sciences Content

LPBI is in alliance with BurstIQ, Denver, CO https://www.burstiq.com/ for Blockchain design for a Transactions Network for Content monetization: B2B and B2C. That process involve Indexing and data migration.

LPBI India will play a role in these tasks as well

Mission #2:

Applications of Synthetic Biology Software to Galectins for design of new drug molecules.

Collaboration with Dr. Raphael Nir of ABI Lab and SBH, Inc in Natick, MA. We will have in 4Q’2021 a dedicated meeting on Mission #2.
LPBI India will play a role in these tasks, please review:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877766/

LPBI USA has interest in Synthetic Biology Software for Drug Discovery and has two scientists with expertise in Galectins as therapeutic targets
Scientists love Synthetic Biology – designing drug molecules using Software – igem.org

https://igem.org/Software

A repository of open source software tools.

Community driven data exchange standards.

Specific software frameworks built explicitly for synthetic biology.

LPBI USA will have a DropBox Folder with all the Synthetic Biology Software accessible to LPBI India
Mentorship and training will be offered by LPBI USA

At LPBI India, been considered for the Leadership function for Mission #2: TBA

STRATEGIC PLAN for Mission #2

We will have in 4Q’2021 a JOINT meeting between LPBI USA, LPBI India with Dr. Raphael Nir of ABI Lab and SBH, Inc in Natick, MA on Mission #2.
A collaboration between LPBI Lead on Mission #2 and Dr. Nir is expected

AGENDA

Zoom of LPBI INDIA Launch on Monday July 19, 2021 at 11AM EST

PRESENTATIONS

Prof. Stephen J. Williams, LPBI USA, Chief Scientific Officer and Board Member is with LPBI USA since 9/2012 will have presentation

From High-Throughput Assay to Systems Biology: New Tools for Drug Discovery

Curator: Stephen J. Williams, PhD

https://pharmaceuticalintelligence.com/2021/07/19/from-high-throughput-assay-to-systems-biology-new-tools-for-drug-discovery/

Aviva will have presentation

Engineering Life: A Review of Synthetic Biology

Martin M. Hanczyc

Author and Article Information

Artificial Life (2020) 26 (2): 260–273.

https://doi.org/10.1162/artl_a_00318

Galectins as Molecular Targets for Therapeutic Intervention

Ruud P. M. Dings,¹ Michelle C. Miller,² Robert J. Griffin,¹ and Kevin H. Mayo^2,*

Int J Mol Sci. 2018 Mar; 19(3): 905.

Published online 2018 Mar 19. doi: 10.3390/ijms19030905

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877766/

Senior Level at LPBI India

LPBI India TEAM Members BIO Presentations: Each of the members of LPBI India will present their BIO in <5 minutes, starting with

Dr. Sudipta Saha, PhD Prof. at Amity University, New Delhi. Dr. Saha is with LPBI USA since 9/2012, Expert, Author and Co-Editor

http://www.amazon.com/dp/B08VTFWVKM

Available on Amazon.com since 2/2/2021

https://www.amazon.com/dp/B075CXHY1B

On Amazon.com since September 4, 2017

PLEASE WATCH

Podcast with Dr. Sudipta Saha, PhD, Interview by Gail S. Thornton, PhDc, Narrator’s Voice: Gail S. Thornton, PhDc

Podcast with Dr. Sudipta Saha, PhD, Interview by Gail S. Thornton, PhDc, Narrator’s Voice: Gail S. Thornton, PhDc

Dr. Vivek Lal, MD, COO, Ambujanagar Multi-specialty Hospital, Ambujanagar, Dist. Gir-Somnath, Gujarat, India.

Paper collaboration with Dr. Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN on 9/2013, article has ~15,000 e-Readers https://pharmaceuticalintelligence.com/2013/09/23/do-novel-anticoagulants-affect-the-ptinr-the-cases-of-xarelto-rivaroxaban-and-pradaxa-dabigatran/

Vivek Lal, MBBS, MD, F.Cl.R. (Lt. Col – Retired), Expert, Author, Writer

https://pharmaceuticalintelligence.com/contributors-biographies/inventors-biologics/indraneel-ghosh-phd-inventor-biologics-lead-on-lpbi-india-synthetic-biology-drug-discovery-team/

Advisor to LPBI USA – Dr. Ajay Gupta of UC, Irvine, Scientific Advisor to LPBI USA, frequent presentation on LPBI’s SCIENCE SIDE – Global Monthly Zoom

PRESENTATION POSTPONED – Ten Minutes on on Clinical Trials for RAMATROBAN – Opportunities for Collaboration between His Company in USA & LPBI India, Dr. Lal’s Hospital and other Hospitals in India

Ramatroban is a thromboxane receptor antagonist. It is also a DP₂ receptor antagonist. It is indicated for the treatment of coronary artery disease. It has also been used for the treatment of asthma. Wikipedia

ChemSpider ID: 110413

Molar mass: 416.47 g·mol⁻¹

Formula: C₂₁H₂₁FN₂O₄S

Members of Technical Staff (MTS) at LPBI India & LPBI USA

All LPBI India MTS currently working on Mission #1 and
All LPBI USA MTS currently working on IT/Data Science Projects

will be invited to considered Mission #2.
An Up-to-date CV in Biological Sciences REQUIRES DEMONSTRATION of making contributions with mentorship in both areas: Mission #1 and Mission #2

LPBI India and LPBI USA MTS – BIO Presentations: PostDocs, Masters and Students will present their Bios in <4 minutes:

Dr. Pati, PostDoc
Ms. Kaur, MSc
Mr. Choudhary, Student IITK
LPBI USA – Mr. Sriram, Student Westford Academy, MA – Born in India, thus, LPBI USA & LPBI India
LPBI USA – Mr. Anand, Student Westford Academy, MA – Born in India, thus, LPBI USA & LPBI India
LPBI USA – Mr. Ethan Coomber, Middlebury College, VT – Research Assistant 3, Text to Audio Conversion and Twitter Analytics
Ms. Vaishnavee Joshi, MSc – Joining LPBI India on 8/15/2021
Ms. Komal Ingle, Msc – Joining LPBI India on 8/15/2021

Alumni of LPBI USA are invited to join us on Monday, July 19, 2021, 11AM EST

Dr. Probodh Kandala, PhD, Regulatory Affairs Manager @ IQVIA Biotech; Drug Development Leader, Expert, Author, Writer with scientific reporting articles in multiple of LPBI e-Books, chiefly Cancer and Immunology
Dr. Ritu Saxena, PhD, Astellas Pharma US, Co-Editor, LPBI’s Series C, Volume 1
- http://www.amazon.com/dp/B013RVYR2K

Dr. Aviral Vatsa, MD, NHS Education for Scotland, Co-Editor, LPBI’s Series A, Volume 1
- http://www.amazon.com/dp/B00DINFFYC
Aashir Awan, Research Scientist, Bristol Myers Squibb, Expert, Author, Writer (EAW) for PharmaceuticalIntelligence.com
Anamika Sarkar, Regeneron, EAW at LPBI 2014-2016